The effect of intravenous magnesium sulfate on serum levels of N-terminal pro-brain natriuretic peptide (NT pro-BNP) in elective CABG with cardiopulmonary bypass

Journal of Anesthesia

Volumn 27, Issue 5, 2013, Pages 693-698

  Dabbagh, Ali ^a   Bastanifar, Ehsan ^a   Foroughi, Mahnoosh ^a   Rajaei, Samira ^b   Keramatinia, Ali Asghar ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CABG; Cardiopulmonary bypass; Magnesium sulfate; N terminal pro brain natriuretic peptide

Indexed keywords

ADRENALIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRACURIUM BESILATE; CALCIUM ION; CISATRACURIUM; CREATININE; DOPAMINE; MAGNESIUM; MAGNESIUM SULFATE; MIDAZOLAM; MILRINONE; MORPHINE SULFATE; PLACEBO; SUFENTANIL; THIOPENTAL;

ADULT; AGED; ANALYZER; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDARTERECTOMY; FEMALE; HUMAN; IMMUNOASSAY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; THORAX RADIOGRAPHY;

ADMINISTRATION, INTRAVENOUS; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; HUMANS; MAGNESIUM SULFATE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; SURGICAL PROCEDURES, ELECTIVE;

EID: 84885956705     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-013-1610-z     Document Type: Article

References (17)

1. Foroughi M, Rahimian H, Dabbagh A, Majidi M, Hekmat M, Beheshti M, Shahzamani M. Postoperative N-terminal pro-brain natriuretic peptide level in coronary artery bypass surgery with ventricular dysfunction after perioperative glucose-insulin-potassium treatment. J Cardiothorac Vasc Anesth. 2012. [Epub ahead of print].
2. Yasser Mohamed Amr, Elmistekawy E, El-Serogy H. Effects of dexamethasone on pulmonary and renal functions in patients undergoing CABG with cardiopulmonary bypass. Semin Cardiothorac Vasc Anesth. 2009; 13(4):231-7.
3. Chaney MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest. 2002;121(3):921-31.
4. Dabbagh A, Elyasi H, Razavi SS, Fathi M, Rajaei S. Intravenous magnesium sulfate for post-operative pain in patients undergoing lower limb orthopedic surgery. Acta Anaesthesiol Scand. 2009;53(8):1088-91.
5. Ferasatkish R, Dabbagh A, Alavi M, Mollasadeghi G, Hydarpur E, Moghadam AA, Faritus ZS, Totonchi MZ. Effect of magnesium sulfate on extubation time and acute pain in coronary artery bypass surgery. Acta Anaesthesiol Scand. 2008;52(10):1348-52.
6. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, Darzi AW, Athanasiou T. The inflammatory response to cardiopulmonary bypass: part 1 - mechanisms of pathogenesis. J Cardiothorac Vasc Anesth. 2009;23(2):223-31.
7. Warren OJ, Watret AL, de Wit KL, Alexiou C, Vincent C, Darzi AW, Athanasiou T. The inflammatory response to cardiopulmonary bypass: part 2 - anti-inflammatory therapeutic strategies. J Cardiothorac Vasc Anesth. 2009;23(3):384-93.
8. James MF. Magnesium: an emerging drug in anaesthesia. Br J Anaesth. 2009;103(4):465-7.
9. Kurian GA, Paddikkala J. N-acetylcysteine and magnesium improve biochemical abnormalities associated with myocardial ischaemic reperfusion in South Indian patients undergoing coronary artery bypass grafting: a comparative analysis. Singapore Med J. 2010;51(5):381-8.
10. Mebazaa MS, Ouerghi S, Frikha N, Moncer K, Mestiri T, James MF, Ben Ammar MS. Is magnesium sulfate by the intrathecal route efficient and safe? Ann Fr Anesth Reanim. 2011;30(1):47-50.
11. Caputo M, Santo KC, Angelini GD, Fino C, Agostini M, Grossi C, Suleiman MS, Reeves BC. Warm-blood cardioplegia with low or high magnesium for coronary bypass surgery: a randomised controlled trial. Eur J Cardiothorac Surg. 2011;40(3):722-9.
12. Dabrowski W. Magnesium supplementation significantly reduces serum S100beta concentrations in patients who have undergone coronary artery bypass surgery. Magnes Res. 2009;22(1):21-31.
13. Dabrowski W, Rzecki Z, Czajkowski M, Pilat J, Wacinski P, Kotlinska E, Sztanke M, Sztanke K, Stazka K, Pasternak K. Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2012;26(3):395-402.
14. Gries A, Bode C, Gross S, Peter K, Böhrer H, Martin E. The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery. Anesth Analg. 1999;88(6):1213-9.
15. Dabbagh A, Rajaei S, Shamsolahrar MH. The effect of intravenous magnesium sulfate on acute postoperative bleeding in elective coronary artery bypass surgery. J Perianesth Nurs. 2010;25(5):290-5.
16. Gupta SD, Pal S, Goswami A, Bhadra S, Mandal S, Naskar C, Mukherjee S, Boral D. A comparative study to determine the effect of intravenous magnesium on postoperative bleeding after on pump CABG in patients receiving pre-operative aspirin. Indian J Anaesth. 2009;53(2):197-203.
17. Mathew JP, Podgoreanu MV, Grocott HP, White WD, Morris RW, Stafford-Smith M, Mackensen GB, Rinder CS, Blumenthal JA, Schwinn DA, Newman MF, PEGASUS Investigative Team. Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J Am Coll Cardiol. 2007;49(19):1934-42.